Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Presynaptic dopamine deficit in minimally conscious state patients following traumatic brain injury.

Fridman EA, Osborne JR, Mozley PD, Victor JD, Schiff ND.

Brain. 2019 Jul 1;142(7):1887-1893. doi: 10.1093/brain/awz118.

PMID:
31505542
2.

George de Hevesy in America.

Osborne JR, Klingensmith WC 3rd.

J Nucl Med. 2019 Jul 13. pii: jnumed.119.233254. doi: 10.2967/jnumed.119.233254. [Epub ahead of print] No abstract available.

PMID:
31302636
3.

Thyroid Cancer Bone Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.

Kondraciuk JD, Rice SL, Zhou X, Gharzeddine K, Knezevic A, Spratt DE, Sabra M, Larson SM, Grewal RK, Osborne JR.

Clin Nucl Med. 2019 Aug;44(8):e465-e471. doi: 10.1097/RLU.0000000000002626.

PMID:
31274625
4.

Carotid Plaque Positron Emission Tomography Imaging and Cerebral Ischemic Disease.

Chaker S, Al-Dasuqi K, Baradaran H, Demetres M, Delgado D, Nehmeh S, Osborne JR, Christos PJ, Kamel H, Gupta A.

Stroke. 2019 Aug;50(8):2072-2079. doi: 10.1161/STROKEAHA.118.023987. Epub 2019 Jul 5.

PMID:
31272325
5.

Molecular imaging and therapy of somatostatin receptor positive tumors.

Ivanidze J, Roytman M, Sasson A, Skafida M, Fahey TJ 3rd, Osborne JR, Dutruel SP.

Clin Imaging. 2019 Jul - Aug;56:146-154. doi: 10.1016/j.clinimag.2019.04.006. Epub 2019 Apr 15. Review.

PMID:
31121520
6.

Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.

Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, Schaeffer EM, Roach M 3rd, Pisansky TM, Shipley WU, Freedland SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, Spratt DE.

JAMA Oncol. 2019 Jul 1;5(7):975-983. doi: 10.1001/jamaoncol.2019.0826.

7.

Thyroid Cancer Brain Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.

Osborne JR, Kondraciuk JD, Rice SL, Zhou X, Knezevic A, Spratt DE, Sabra M, Larson SM, Grewal RK.

Clin Nucl Med. 2019 Jul;44(7):544-549. doi: 10.1097/RLU.0000000000002618.

PMID:
31107749
8.

Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas.

Ivanidze J, Roytman M, Lin E, Magge RS, Pisapia DJ, Liechty B, Karakatsanis N, Ramakrishna R, Knisely J, Schwartz TH, Osborne JR, Pannullo SC.

J Neuroimaging. 2019 Sep;29(5):650-656. doi: 10.1111/jon.12632. Epub 2019 May 20.

PMID:
31107591
9.

Cancer Health Impact Program (CHIP): Identifying Social and Demographic Associations of mHealth Access and Cancer Screening Behaviors Among Brooklyn, New York, Residents.

Camacho-Rivera M, Rice SL, Oh S, Paris M, Akpara E, Molina J, Obadina M, Mcmillan S, Aracena JLM, Morency J, Muniz RC, Gany F, Brown CL, Gonsky J, Osborne JR.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):478-485. doi: 10.1158/1055-9965.EPI-18-0788. Epub 2019 Feb 7.

PMID:
30733308
10.

Theragnostic Target, Prostate-Specific Membrane Antigen-Also Specific for Nonprostatic Malignancies.

Ramirez-Fort MK, Mahase SS, Osborne JR, Lange CS.

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):646-649. doi: 10.1016/j.ijrobp.2018.03.061. Epub 2018 Apr 5. No abstract available.

PMID:
29893276
11.

Interventional Cultural and Language Assistance Program: Associations between Cultural and Linguistic Factors and Satisfaction with Cancer Care.

Costas-Muniz R, Amir J, Paris M, Spratt D, Arevalo-Perez J, Fareedy S, González CJ, Gany F, Camacho-Rivera M, Osborne JR.

J Community Med Health Educ. 2017;7(1). pii: 503. doi: 10.4172/2161-0711.1000503. Epub 2017 Feb 20.

12.

Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.

Fox JJ, Gavane SC, Blanc-Autran E, Nehmeh S, Gönen M, Beattie B, Vargas HA, Schöder H, Humm JL, Fine SW, Lewis JS, Solomon SB, Osborne JR, Veach D, Sawyers CL, Weber WA, Scher HI, Morris MJ, Larson SM.

JAMA Oncol. 2018 Feb 1;4(2):217-224. doi: 10.1001/jamaoncol.2017.3588.

13.

Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer Outcomes.

Spratt DE, Chen YW, Mahal BA, Osborne JR, Zhao SG, Morgan TM, Palapattu G, Feng FY, Nguyen PL.

Eur Urol Focus. 2016 Dec;2(5):532-539. doi: 10.1016/j.euf.2016.03.010. Epub 2016 Apr 1.

PMID:
28723519
14.

Erratum to: Repeatability of [68Ga]DKFZ11-PSMA PET Scans for Detecting Prostate-specific Membrane Antigen-positive Prostate Cancer.

Osborne JR, Kalidindi TM, Punzalan BJ, Gangangari K, Spratt DE, Weber WA, Larson SM, Pillarsetty NVK.

Mol Imaging Biol. 2017 Dec;19(6):952. doi: 10.1007/s11307-017-1104-8. No abstract available.

PMID:
28695370
15.

Repeatability of [68Ga]DKFZ11-PSMA PET Scans for Detecting Prostate-specific Membrane Antigen-positive Prostate Cancer.

Osborne JR, Kalidindi TM, Punzalan BJ, Gangangari K, Spratt DE, Weber WA, Larson SM, Pillarsetty NVK.

Mol Imaging Biol. 2017 Dec;19(6):944-951. doi: 10.1007/s11307-017-1091-9. Erratum in: Mol Imaging Biol. 2017 Jul 10;:.

16.

Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations.

Huang FW, Mosquera JM, Garofalo A, Oh C, Baco M, Amin-Mansour A, Rabasha B, Bahl S, Mullane SA, Robinson BD, Aldubayan S, Khani F, Karir B, Kim E, Chimene-Weiss J, Hofree M, Romanel A, Osborne JR, Kim JW, Azabdaftari G, Woloszynska-Read A, Sfanos K, De Marzo AM, Demichelis F, Gabriel S, Van Allen EM, Mesirov J, Tamayo P, Rubin MA, Powell IJ, Garraway LA.

Cancer Discov. 2017 Sep;7(9):973-983. doi: 10.1158/2159-8290.CD-16-0960. Epub 2017 May 17.

17.

Pan-Cancer Analysis of Genomic Sequencing Among the Elderly.

Wahl DR, Nguyen PL, Santiago M, Yousefi K, Davicioni E, Shumway DA, Speers C, Mehra R, Feng FY, Osborne JR, Spratt DE.

Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):726-732. doi: 10.1016/j.ijrobp.2017.01.002. Epub 2017 Jan 7.

PMID:
28258894
18.

Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer.

Larson SM, Osborne JR, Grewal RK, Tuttle RM.

Mol Imaging Radionucl Ther. 2017 Feb 9;26(Suppl 1):80-86. doi: 10.4274/2017.26.suppl.09.

19.

Anatomic and functional imaging in the diagnosis of spine metastases and response assessment after spine radiosurgery.

Soliman M, Taunk NK, Simons RE, Osborne JR, Kim MM, Szerlip NJ, Spratt DE.

Neurosurg Focus. 2017 Jan;42(1):E5. doi: 10.3171/2016.9.FOCUS16350. Review.

PMID:
28041315
20.

miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin.

Das DK, Naidoo M, Ilboudo A, Park JY, Ali T, Krampis K, Robinson BD, Osborne JR, Ogunwobi OO.

Exp Cell Res. 2016 Nov 1;348(2):190-200. doi: 10.1016/j.yexcr.2016.09.021. Epub 2016 Sep 29.

21.

Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.

Spratt DE, Vargas HA, Zumsteg ZS, Golia Pernicka JS, Osborne JR, Pei X, Zelefsky MJ.

Eur Urol. 2017 Jan;71(1):37-43. doi: 10.1016/j.eururo.2016.07.043. Epub 2016 Aug 11.

22.

Racial/Ethnic Disparities in Genomic Sequencing.

Spratt DE, Chan T, Waldron L, Speers C, Feng FY, Ogunwobi OO, Osborne JR.

JAMA Oncol. 2016 Aug 1;2(8):1070-4. doi: 10.1001/jamaoncol.2016.1854.

23.

miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer.

Das DK, Osborne JR, Lin HY, Park JY, Ogunwobi OO.

Transl Oncol. 2016 Jun;9(3):236-41. doi: 10.1016/j.tranon.2016.04.005. Epub 2016 May 19.

24.

Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.

Shady W, Kishore S, Gavane S, Do RK, Osborne JR, Ulaner GA, Gonen M, Ziv E, Boas FE, Sofocleous CT.

Eur J Radiol. 2016 Jun;85(6):1224-31. doi: 10.1016/j.ejrad.2016.03.029. Epub 2016 Mar 31.

25.

Radium-223 outcomes after multiple lines of metastatic castration-resistant prostate cancer therapy in clinical practice: implication of pre-treatment spinal epidural disease.

Spratt DE, Osborne JR, Zumsteg ZS, Rebeiz K, Leeman J, Rivera A, Morris MJ, Zelefsky MJ.

Prostate Cancer Prostatic Dis. 2016 Sep;19(3):271-6. doi: 10.1038/pcan.2016.14. Epub 2016 Apr 26.

PMID:
27112529
26.

Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study.

Leeman JE, Bilsky M, Laufer I, Folkert MR, Taunk NK, Osborne JR, Arevalo-Perez J, Zatcky J, Alektiar KM, Yamada Y, Spratt DE.

J Neurosurg Spine. 2016 Jul;25(1):52-8. doi: 10.3171/2015.11.SPINE151059. Epub 2016 Mar 4.

27.

The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study.

Spratt DE, Beadle BM, Zumsteg ZS, Rivera A, Skinner HD, Osborne JR, Garden AS, Lee NY.

Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):523-531. doi: 10.1016/j.ijrobp.2015.11.007. Epub 2015 Nov 11.

28.

Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling.

Fung EK, Cheal SM, Fareedy SB, Punzalan B, Beylergil V, Amir J, Chalasani S, Weber WA, Spratt DE, Veach DR, Bander NH, Larson SM, Zanzonico PB, Osborne JR.

EJNMMI Res. 2016 Dec;6(1):7. doi: 10.1186/s13550-016-0164-0. Epub 2016 Jan 22.

29.

PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer?

Ilboudo A, Chouhan J, McNeil BK, Osborne JR, Ogunwobi OO.

Int J Environ Res Public Health. 2015 Dec 22;13(1):ijerph13010012. doi: 10.3390/ijerph13010012.

30.

A Perspective of the Future of Nuclear Medicine Training and Certification.

Arevalo-Perez J, Paris M, Graham MM, Osborne JR.

Semin Nucl Med. 2016 Jan;46(1):88-96. doi: 10.1053/j.semnuclmed.2015.10.003. Review.

31.

Guest Editorial.

Osborne JR.

Semin Nucl Med. 2016 Jan;46(1):3-4. doi: 10.1053/j.semnuclmed.2015.10.002. No abstract available.

PMID:
26687852
32.

ACR Practice Parameter for the Performance of Therapy With Unsealed Radiopharmaceutical Sources.

Spratt DE, Zaki BI, Franc BL, Hartford AC, Osborne JR.

Clin Nucl Med. 2016 Feb;41(2):106-17. doi: 10.1097/RLU.0000000000001036.

PMID:
26646993
33.

Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.

Debernard L, Melzer TR, Alla S, Eagle J, Van Stockum S, Graham C, Osborne JR, Dalrymple-Alford JC, Miller DH, Mason DF.

Psychiatry Res. 2015 Dec 30;234(3):352-61. doi: 10.1016/j.pscychresns.2015.10.004. Epub 2015 Oct 22.

PMID:
26602610
34.

Roundtable on the Future of Nuclear Medicine Training.

Osborne JR, Beylergil V, Samitt C, Graham MM.

J Nucl Med. 2015 Dec;56(12):1966-9. doi: 10.2967/jnumed.115.165621. Epub 2015 Oct 1. No abstract available.

35.

Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases.

Spratt DE, Arevalo-Perez J, Leeman JE, Gerber NK, Folkert M, Taunk NK, Alektiar KM, Karimi S, Lyo JK, Tap WD, Bilsky MH, Laufer I, Yamada Y, Osborne JR.

Spine J. 2016 Mar;16(3):291-8. doi: 10.1016/j.spinee.2015.08.041.

36.

Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.

Hogan MP, Goldman DA, Dashevsky B, Riedl CC, Gönen M, Osborne JR, Jochelson M, Hudis C, Morrow M, Ulaner GA.

J Nucl Med. 2015 Nov;56(11):1674-80. doi: 10.2967/jnumed.115.161455. Epub 2015 Aug 20.

37.

Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes.

Sofocleous CT, Violari EG, Sotirchos VS, Shady W, Gonen M, Pandit-Taskar N, Petre EN, Brody LA, Alago W, Do RK, D'Angelica MI, Osborne JR, Segal NH, Carrasquillo JA, Kemeny NE.

Clin Colorectal Cancer. 2015 Dec;14(4):296-305. doi: 10.1016/j.clcc.2015.06.003. Epub 2015 Jun 27.

38.

A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer.

Pandit-Taskar N, O'Donoghue JA, Durack JC, Lyashchenko SK, Cheal SM, Beylergil V, Lefkowitz RA, Carrasquillo JA, Martinez DF, Fung AM, Solomon SB, Gönen M, Heller G, Loda M, Nanus DM, Tagawa ST, Feldman JL, Osborne JR, Lewis JS, Reuter VE, Weber WA, Bander NH, Scher HI, Larson SM, Morris MJ.

Clin Cancer Res. 2015 Dec 1;21(23):5277-85. doi: 10.1158/1078-0432.CCR-15-0552. Epub 2015 Jul 14.

39.

Disparities in castration-resistant prostate cancer trials.

Spratt DE, Osborne JR.

J Clin Oncol. 2015 Apr 1;33(10):1101-3. doi: 10.1200/JCO.2014.58.1751. Epub 2015 Feb 17. No abstract available.

40.

99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer.

Vallabhajosula S, Nikolopoulou A, Babich JW, Osborne JR, Tagawa ST, Lipai I, Solnes L, Maresca KP, Armor T, Joyal JL, Crummet R, Stubbs JB, Goldsmith SJ.

J Nucl Med. 2014 Nov;55(11):1791-8. doi: 10.2967/jnumed.114.140426. Epub 2014 Oct 23.

41.

⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer.

Pandit-Taskar N, O'Donoghue JA, Beylergil V, Lyashchenko S, Ruan S, Solomon SB, Durack JC, Carrasquillo JA, Lefkowitz RA, Gonen M, Lewis JS, Holland JP, Cheal SM, Reuter VE, Osborne JR, Loda MF, Smith-Jones PM, Weber WA, Bander NH, Scher HI, Morris MJ, Larson SM.

Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2093-105. doi: 10.1007/s00259-014-2830-7. Epub 2014 Aug 21.

42.

Utility of FDG-PET in clinical neuroendocrine prostate cancer.

Spratt DE, Gavane S, Tarlinton L, Fareedy SB, Doran MG, Zelefsky MJ, Osborne JR.

Prostate. 2014 Aug;74(11):1153-9. doi: 10.1002/pros.22831. Epub 2014 Jun 9.

43.

Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma.

Cheal SM, Punzalan B, Doran MG, Evans MJ, Osborne JR, Lewis JS, Zanzonico P, Larson SM.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):985-94. doi: 10.1007/s00259-013-2679-1. Epub 2014 Mar 7.

44.

A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy.

Osborne JR, Green DA, Spratt DE, Lyashchenko S, Fareedy SB, Robinson BD, Beattie BJ, Jain M, Lewis JS, Christos P, Larson SM, Bander NH, Scherr DS.

J Urol. 2014 May;191(5):1439-45. doi: 10.1016/j.juro.2013.10.041. Epub 2013 Oct 14.

45.

PSMA-targeted dendrimers: a patent evaluation (WO2012078534).

Akhtar NH, Osborne JR, Fareedy SB, Tagawa ST.

Expert Opin Ther Pat. 2013 May;23(5):665-8. doi: 10.1517/13543776.2013.789501. Epub 2013 Apr 13.

PMID:
23581819
46.
47.

Prostate-specific membrane antigen-based imaging.

Osborne JR, Akhtar NH, Vallabhajosula S, Anand A, Deh K, Tagawa ST.

Urol Oncol. 2013 Feb;31(2):144-54. doi: 10.1016/j.urolonc.2012.04.016. Epub 2012 May 31. Review.

48.

A worrisome interventricular septum: more than meets the eye.

Wilson SR, Leonard JP, Geyer JT, Osborne JR, Weinsaft JW.

J Am Coll Cardiol. 2011 Dec 6;58(24):e43. doi: 10.1016/j.jacc.2011.06.069. No abstract available.

49.

18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.

Palaskas N, Larson SM, Schultz N, Komisopoulou E, Wong J, Rohle D, Campos C, Yannuzzi N, Osborne JR, Linkov I, Kastenhuber ER, Taschereau R, Plaisier SB, Tran C, Heguy A, Wu H, Sander C, Phelps ME, Brennan C, Port E, Huse JT, Graeber TG, Mellinghoff IK.

Cancer Res. 2011 Aug 1;71(15):5164-74. doi: 10.1158/0008-5472.CAN-10-4633. Epub 2011 Jun 6.

50.

DNMT3A mutations in acute myeloid leukemia.

Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, Kandoth C, Payton JE, Baty J, Welch J, Harris CC, Lichti CF, Townsend RR, Fulton RS, Dooling DJ, Koboldt DC, Schmidt H, Zhang Q, Osborne JR, Lin L, O'Laughlin M, McMichael JF, Delehaunty KD, McGrath SD, Fulton LA, Magrini VJ, Vickery TL, Hundal J, Cook LL, Conyers JJ, Swift GW, Reed JP, Alldredge PA, Wylie T, Walker J, Kalicki J, Watson MA, Heath S, Shannon WD, Varghese N, Nagarajan R, Westervelt P, Tomasson MH, Link DC, Graubert TA, DiPersio JF, Mardis ER, Wilson RK.

N Engl J Med. 2010 Dec 16;363(25):2424-33. doi: 10.1056/NEJMoa1005143. Epub 2010 Nov 10.

Supplemental Content

Loading ...
Support Center